Patents by Inventor Michael J. Kerins

Michael J. Kerins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10993852
    Abstract: An absorbent garment has a minimum crotch width less than 30% the front region width. The absorbent garment has an absorbent member minimum width less than 80 mm. The absorbent member minimum width is less than 53% the minimum crotch width and is less than 60% the absorbent member maximum width.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: May 4, 2021
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: Marie E. Boll, Kimberly Louise Ellefson, Ligia A. Rivera, Tammy J. Nettekoven, Kimberly M. Downs, Todd R. Hagner, Marlene R. Dins, Ronald Alex Hilt, Michael J. Kerins
  • Publication number: 20180085263
    Abstract: An absorbent garment has a minimum crotch width less than 30% the front region width. The absorbent garment has an absorbent member minimum width less than 80 mm. The absorbent member minimum width is less than 53% the minimum crotch width and is less than 60% the absorbent member maximum width.
    Type: Application
    Filed: April 29, 2015
    Publication date: March 29, 2018
    Inventors: Marie E. Boll, Kimberly Louise Ellefson, Ligia A. Rivera, Tammy J. Nettekoven, Kimberly M. Downs, Todd R. Hagner, Marlene R. Dins, Ronald Alex Hilt, Michael J. Kerins
  • Publication number: 20170002428
    Abstract: Biomarkers suitable for use in the diagnosis and prognosis of a number of cancers are identified and provided. Also, there are improved methods for the identification and quantification of such biomarkers in samples taken from patients.
    Type: Application
    Filed: August 3, 2016
    Publication date: January 5, 2017
    Inventors: Michael J. Kerin, Nicola Miller, Helen Heneghan
  • Publication number: 20150141280
    Abstract: The invention provides methods of and diagnostic kits for the detection of breast cancer, in particular luminal A breast cancer, or to assist in assessing the prognosis, or determine the efficacy of a treatment regimen for breast cancer comprising at least one oligonucleotide probe capable of binding to at least a portion of a circulating miRNA selected from the group comprising the miR-181a and miR-652 biomarkers. The invention also provides methods of identifying a therapeutic agent capable of preventing or treating cancers, including breast cancer, comprising testing the ability of the potential therapeutic agent to enhance the expression of at least one protein selected from the group comprising miR-181a and miR-652.
    Type: Application
    Filed: July 4, 2013
    Publication date: May 21, 2015
    Inventors: Michael J. Kerin, Nicola Miller, Ailbhe McDermott
  • Publication number: 20150072883
    Abstract: The present invention relates to the identification of biomarkers suitable for use in the diagnosis and prognosis of a number of cancers. In addition, the invention relates to improved methods for the identification and quantification of such biomarkers in samples taken from patients.
    Type: Application
    Filed: June 24, 2014
    Publication date: March 12, 2015
    Inventors: Michael J. Kerin, Nichola Miller, Helen Heneghan
  • Publication number: 20130130927
    Abstract: The present invention relates to the identification of circulating miRNAs as biomarkers suitable for use in the diagnosis and prognosis of a number of cancers, in particular breast cancer. In addition, the invention relates to improved methods for the identification and quantification of such biomarkers in samples taken from patients.
    Type: Application
    Filed: March 10, 2011
    Publication date: May 23, 2013
    Inventors: Helen Heneghan, Nicola Miller, Michael J. Kerin
  • Publication number: 20120040353
    Abstract: The present invention relates to the identification of biomarkers suitable for use in the diagnosis and prognosis of a number of cancers. In addition, the invention relates to improved methods for the identification and quantification of such biomarkers in samples taken from patients.
    Type: Application
    Filed: March 11, 2011
    Publication date: February 16, 2012
    Applicant: NATIONAL UNIVERSITY OF IRELAND, GAWAY
    Inventors: Michael J. Kerin, Nicola Miller, Helen Heneghan